GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Relb | increases expression | EXP | | 6480464 | CTD | Cisplatin results in increased expression of RELB mRNA | PMID:26546572 | Relb | multiple interactions | EXP | | 6480464 | CTD | [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of ADH7 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of AK3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of ANK3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of ASPG mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CAMK2D mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CAR5B mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CASP1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CASP12 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CLDN1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of COL4A5 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of COL6A2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CYP39A1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CYP3A13 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of FBLN2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of FRK mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of FRMD4B mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of GBE1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of HACD4 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of HSD17B11 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of IL1RN mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of KRT12 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of LOXL3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of LRP2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of MGST2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of MME mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of MYO6 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of NT5C2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of OXCT1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of P3H2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of PCCA mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of PHKB mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of SEMA3C mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of SLC22A4 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of SPIB mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of SPRR1A mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of TRIM2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of UBD mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ARHGEF3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of CD83 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of COL4A1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of COL4A2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of CSTF3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of CTSH mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of DENND2C mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ELOVL4 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of EPHB3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of FUBP1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of GJB2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of HEY2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of KCNQ1OT1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of LCORL mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of LRATD2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of LUC7L2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of NIPAL1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of PSRC1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of PTP4A3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of RAB14 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of RAP1A mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of RHPN1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of SEC14L2 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of STBD1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of TMTC3 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of TRP53I11 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of TRPC1 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of TTC9 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of UBXN2B mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ZFP37 mRNA; [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ZFR mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of ANGPTL4 mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of APOBEC1 mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of IL15RA mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of LAYN mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of MAF mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of MAP3K6 mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of NRIP2 mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of PLTP mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of RGS3 mRNA; [Cisplatin co-treated with RELB mutant form] results in decreased expression of SUCLG2 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of ARAP2 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of CDC42BPG mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of CELSR2 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of CSF1 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of GRB10 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of KLF7 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of KLHL23 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of NDRG4 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of NKAIN1 mRNA; [Cisplatin co-treated with RELB mutant form] results in increased expression of POLR3GL mRNA | PMID:23625948 | Relb | increases expression | ISO | RELB (Homo sapiens) | 6480464 | CTD | Cisplatin results in increased expression of RELB mRNA | PMID:27594783 | Relb | multiple interactions | ISO | RELB (Homo sapiens) | 6480464 | CTD | [Cisplatin co-treated with jinfukang] results in decreased expression of RELB mRNA | PMID:27392435 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |